PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-46.40%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-61.49%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-408.27%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-408.27%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-339.14%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-346.43%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-342.86%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.13%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.67%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-146.15%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
4.83%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
214.06%
10Y revenue/share CAGR at 50-75% of MRVL's 387.08%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-8.16%
Negative 5Y CAGR while MRVL stands at 74.22%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-21.22%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-413.82%
Negative 10Y OCF/share CAGR while MRVL stands at 2005.39%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-1784.49%
Negative 5Y OCF/share CAGR while MRVL is at 123.38%. Joel Greenblatt would question the firm’s operational model or cost structure.
-109.14%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-947.67%
Negative 10Y net income/share CAGR while MRVL is at 88.19%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-650.66%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-256.25%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
1510.75%
Positive growth while MRVL is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
105.29%
5Y equity/share CAGR above 1.5x MRVL's 44.45%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
70.43%
3Y equity/share CAGR above 1.5x MRVL's 16.85%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-47.61%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.64%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-8.17%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-2.61%
We have a declining book value while MRVL shows 0.47%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.27%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-4.33%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.